Abuses and Apologies: Irresponsible Conduct of Human Subjects Research in Latin America

Reverby S. M. , “‘Normal Exposure” and Inoculation Syphilis: A PHS “Tuskegee” Doctor in Guatemala, 1946–1948,” Journal of Policy History 23, no. 1 (2011): 6–28, at 22.

Latin America in this context includes all of the Americas south of the United States, including English-speaking countries, e.g., Belize, and French-speaking countries, e.g., French Guiana.

Luna F. , Bioethics and Vulnerability: A Latin American View (Amsterdam: Rodolpi, 2006): at 16.

Kaiser J. , “Panel Blasts Ethics, Science of 1940s Guatemala Studies,” Science 333, no. 6047 (2011): 1211.

The Lancet editorial staff, “Ethical Behavior in Clinical Research – A Lesson from the Past,” The Lancet 378, 9795 (2011): 962.

Id.

The President's Commission for the Study of Bioethical Issues, Executive Summary Report, “Research across Borders: Proceedings of the International Research Panel of the Presidential Commission for the Study of Bioethical Issues,” 2011, available at <http://bioethics.gov/cms/sites/default/files/IRP-Proceedings%20and%20Recommendations_0.pdf> (last visited February 27, 2013).

DeYoung K. and Nelson D. , “Latin America Is Ripe for Trials and Fraud,” Washington Post, December 21, 2000, available at <http://www.washingtonpost.com/ac2/wp-dyn/A31027-2000Dec20> (last visited January 1, 2012).

Weyzig F. and Schipper I. , SOMO in collaboration with Wemos Foundation, briefing paper on ethics in clinical trials, “Examples of Unethical Trials,” February 2008, 1–16.

Lavery J. V. Grady C. Wahl E. R. , and Emanuel E. J. , Ethical Issues in International Biomedical Research: A Casebook (New York: Oxford University Press, 2007).

McCarthy M. , “US Company's Plan for Trial in Latin America Draws Fire,” The Lancet 357, no. 9257 (2001): 691.

See McCarthy , supra note 11, at 691.

See Weyzig and Schipper , supra note 9, at 9.

Leighton P. , “Study on Infants in Peru Sparks Controversy,” July, 18, 2006, available at <www.scidev.net/content/news/eng/study-on-infants-in-peru-sparks-ethics-inquiry.cfm> (last visited February 28, 2013).

Hearn K. , “The Rise of Unregulated Drug Trials in South America,” The Nation, September 21, 2011, available at <http://www.thenation.com/print/article/163547/rise-unregulated-drug-trials-south-america> (last visited February 28, 2013).

Evans D. Smith M. , and Willen L. , “Big Pharma's Shameful Secret,” December 2005, available at <http://www.journalism.columbia.edu/system/documents/523/original/2006_Evans_Big_Pharma_s_Shameful_Secret_MAG.pdf> (last visited February 28, 2013).

See Weyzig and Schipper , supra note 9, at 7.

See Evans Smith , and Willen , supra note 16; Weyzig and Schipper , supra note 9, at 7.

Barnes K. , “Troubled SFBC Changes Its Name in Hope of Changing Its Fortunes,” Outsourcing Pharma.com, August 31, 2006, available at <http://www.outsourcing-pharma.com/Clinical-Development/Troubled-SFBC-changes-its-name-in-hope-of-changing-its-fortunes> (last visited February 28, 2013).

Takahashi M. T. Ramos H. F. Pinheiro-Neto C. D. Miziara I. D. , and de Oliveira Ayer R. , “Current Outlook of Ethics in Research with Human Subjects,” Brazilian Journal of Otorhinolaryngology 77, no. 2 (2011): 263–266.

Ribeiro C. R. O. and Zoboli E. L. C. P. , “Poverty, Bioethics and Research,” Revista of Latino-American Enfermagem 15, Spec No (2007): 843–849, at 847.

See Ribeiro and Zoboli , supra 20, at 847.

See Luna , supra 3, at 143.

O'Neill O. , Towards Justice and Virtue (Cambridge: Cambridge University Press, 1996); Ruof M. C. , “Vulnerability, Vulnerable Populations, and Policy,” Kennedy Institute of Ethics Journal 14, no. 4 (2004): 411–425, available at <http://bioethics.georgetown.edu/publications/scopenotes/sn44.pdf> (last visited February 28, 2013).

Hurst S. A. , “Vulnerability in Research and Health Care; Describing the Elephant in the Room?” Bioethics 22, no. 4 (2008): 191–202.

Id., at 195.

Id.

Id., at 196.

Id., at 202 [Note: Hurst explains that her definition of vulnerability “does not address differences in the way that people may have become vulnerable. As has been proposed, differences between vulnerabilities that originate in injustice, or misfortune, or that are the fault of the vulnerable person herself, could well be relevant. According to the view proposed here, however, this would affect the legitimacy of the claim being considered, rather than the definition of vulnerability itself.” However, I argue that differences among people can be significant for understanding the variability of wrongs and the “layers” of vulnerability present, and can strengthen the legitimacy of the claims being considered.].

Garrafa V. Solbakk J. H. Vidal S. , and Lorenzo C. , “Between the Needy and the Greedy: The Quest for a Just and Fair Ethics of Clinical Research,” Journal of Medical Ethics 36, no. 8 (2010): 500–504, at 501. See Garrafa Solbakk Vidal , and Lorenzo , supra 30, at 502.

Id., at 502.

Macklin R. , “Bioethics, Vulnerability, and Protection,” Bioethics 17, nos. 5–6 (2003): 472–486, at 475.

La Vertu D. S. and Linares A. M. , “Ethical Principles of Biomedical Research on Human Subjects: Their Application and Limitations in Latin America and the Caribbean,” Bulletin of Pan American Health Organization 24, no. 4 (1990): 469–479.

See Luna , supra 3, at 80.

Ángeles-Llerenas A. R. Wirtz V. Francisco C. , and Álvarez L. , “The Role and Responsibilities of Witnesses in the Informed Consent Process,” Developing World Bioethics 9, no. 1 (2009): 18–25, at 23.

Verástegui E. L. , “Consenting of the Vulnerable: The Informed Consent Procedure in Advanced Cancer Patients in Mexico,” BioMed Central 7, no. 13 (2006): 1–12, available at <http://www.biomedcentral.com/content/pdf/1472-6939-7-13.pdf> (last visited March 3, 2013).

See Angeles-Llerenas Wirtz , and Lara-Alvarez , supra 21.

See Vertu La and Linares , supra 33, at 475–476.

See Takahashi Ramos Pinheiro-Neto Miziara , and de Oliveira Ayer , supra 24, at 266; Freitas C. B. D. and Hossne W. S. , “Pesquisa com seres humanos,” in Costa S. I. F. Oselka G. Garrafa V. , eds., Inicia áo á Bioética (Brazil, Conselho Federal de Medicina, 1998): At 193–204.

See Luna , supra 3, at 135.

Pessini L. de Paul de Barchifontaine C. , and Stepke F. L. , eds., Ibero-American Bioethics: History and Perspectives (New York: Springer, 2009).

See DeYoung and Nelson , supra 8, at web page 5.

Macklin R. , Double Standards in Medical Research in Developing Countries (Cambridge: Cambridge University Press, 2004): at 7.

See Vertu La and Linares , supra 33.

Hurtado M. Hill K. Kaplan H. , and Lancaster J. , “The Epidemiology of Infectious Diseases among South American Indians: A Call for Ethical Research Guidelines,” Current Anthropology 42, no. 3 (2012): 425–432.

See Luna , supra 3.

Kottow M. H. , “Vulnerability: What Kind of Principle Is It?” Medicine, Health Care and Philosophy 7, no. 3 (2005): 281–287; Solbakk J. H. , “Vulnerability: A Futile or Utile Principle in Health Care Ethics?” in Chadwick R. ten Have H. Meslin E. , eds., Health Care Ethics in an Era of Globalisation (London: Sage, 2011); see Garrafa Solbakk Vidal , and Lorenzo , supra 30, at 502.

See Garrafa Solbakk Vidal , and Lorenzo , supra 30.

Id., at 503.

See Luna , supra 3, at 127.

See Hurst , supra 23, at 199.

Carmack H. J. Bates B. R. , and Harter L. M. , “Narrative Constructions of Health Care Issues and Policies: The Case of President Clinton's Apology-by-Proxy for the Tuskegee Syphilis Experiment,” Journal of Medical Humanities 29, no. 2 (2008): 89–109, at 92.

See Carmack Bates , and Harter , supra 52, at 103.

Id., at 98.

Nie J-B. , “The United States Cover-Up of Japanese Wartime Medical Atrocities: Complicity Committed in the National Interest and Two Proposals for Contemporary Action,” American Journal of Bioethics 6, no. 3 (2006): W21–W33, at W21.

See Nie , supra 55, at W28-W29.

See Nie , supra 55, at W29.

Alberstein M. Davidovitch N. Lombardo P. , and Scott C. , “Saying “I'm Sorry”: The Role of Apology in Public Health,” Journal of Law, Medicine & Ethics 35, no. 4, supp. (2007): 132–134.

Davis P. , “On apologies,” Journal of Applied Philosophy 19, no. 2 (2002): 169–173; Souder L. , “A Rhetorical Analysis of Apologies for Scientific Misconduct: Do They Really Mean It?” Science and Engineering Ethics 16, no. 1 (2010): 175–184, at 177.

See Alberstein Davidovitch Lombardo , and Scott , supra note 58, at 133.

See Carmack Bates , and Harter , supra 52, at 97–98.

See Alberstein Davidovitch Lombardo , and Scott , supra 58, at 132.

Bennett C. , “Taking the Sincerity Out of Saying Sorry: Restorative Justice as Ritual,” Journal of Applied Philosophy 23, no. 2 (2006): 128–143; Duff R. A. , Punishment, Communication and Community (Oxford: Oxford University Press, 2001).

Id. (Duff), at 94–95; see Bennett , supra 63, at 138.

See Bennett , supra 63, at 140.

See Bennett , supra 63.

Thompson J. , “An Apology Paradox,” The Philosophical Quarterly 50, no. 201 (2000): 470–475, at 473.

See Thompson , supra 67, at 475.

See Nie , supra 55.

Grady C. , “Ethics of International Research: What Does Responsiveness Mean?” Virtual Mentor, Ethics Journal of the American Medical Association 8, no. 4 (2006): 235–240.

See Carmack Bates , and Harter , supra note 52, at 98.

Voo T-C. Chin J. , and Campbell A.V. , “Multinational Research,” The Hastings Center Bioethics Briefing Book, at 108, available at <http://www.thehastingscenter.org/uploadedFiles/Publications/Briefing_Book/multinational%20research%20chapter.pdf> (last visited January 3, 2012).

Zegers-Hochschild F. , “Barriers to Conducting Clinical Research in Reproductive Medicine: Latin America,” Fertility and Sterility 96, no. 4 (2011): 802–804, at 803.

Barboza M. Minaya G. , and Fuentes D. , “Hacia una comisión nacional de ética de la investigación en salud en perú: Apuntes acerca de rutas y procesos en perspectiva comparada,” Revista Peruana de Medicina Experimental y Salud Publica 27, no. 4 (2010): 621–628.

Lescano A. R. Blazes D. L. Montano S. M. Moran Z. Naquira C. Ramirez E. Lie R. Martin G. J. Lescano A. G. , and Zunt J. R. , “Research Ethics Training in Peru: A Case Study,” PLoS One 3, no. 9 (2008): E3274.

Silva H. Sungar E. Kleinstiver S. J. , and Rubin R. H. , “Opportunities and Challenges for Clinical and Cardiovascular Research in Latin America,” American Journal of Therapeutics 13, no. 4 (2006): 309–314, at 313.

Reverby S. M. , “Listening to Narratives from the Tuskegee Syphilis Study,” The Lancet 377, no. 9778 (2011): 1646–1647, at 1647.